Homeward, Rite Aid team-up to support seniors in rural areas
Rite Aid pharmacists will be able to introduce Medicare-eligible customers to Homeward's clinical services, including annual wellness visits, screenings, and risk assessments.
mPharma taps TytoCare to bring telehealth to pharmacies in Africa
The two companies have already seen success in improving healthcare access in remote communities throughout Ghana, Kenya, Uganda, Zambia, and Nigeria.
FundamentalVR expands into the endovascular space
The company also offers CollaborationVR, a virtual space designed for healthcare professionals to accelerate procedural and product adoption together.
Northwell Health and Aegis Ventures launch Ascertain, a healthcare AI company creation platform
The platform brings $100 million in seed-stage funding and permanent long-term growth capital to systematically launch healthcare AI companies at scale.
CipherHealth unveils CipherConnect, a conversational patient engagement solution
The company also launched a suite of pre-care digital front door solutions powered by CipherConnect to drive appointment volume and reduce no-shows.
Carbon Health launches a diabetes program that integrates continuous at-home and in-person care
The provider brings its omnichannel healthcare approach to chronic condition management and sets the standard for the future of primary care.
Brightline launches virtual coaching program for young children with autism
The Getting an Early Start on Autism Program builds on top of current support models and fills gaps in care by delivering virtual training to caregivers.
Pear Therapeutics to offer its digital therapeutics through telehealth partners
The company's first telehealth offering is with PursueCare to offer patients an end-to-end virtual continuum of comprehensive addiction recovery care.
Rock: Q1 2022 U.S. digital health funding hits $6.0B across 183 deals
Supply chain and energy disruptions, market corrections, and the Russian invasion of Ukraine are new variables entering public and venture funding equations.
Pear Therapeutics ended 2021 with $4.2M in revenue, expects $22M this year
Yes, the digital therapeutics market is taking off...